Cargando…

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study

Objectives: The aim is to evaluate the incidental dose to the lymphatic regions in prostate-only radiotherapy (PORT) and to compare hematological outcome between PORT and whole pelvic radiotherapy (WPRT) in node-positive prostate cancer (pN1 PCa), in the era of modern radiotherapy techniques. Method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonteyne, Valérie, Danckaert, Willeke, Ost, Piet, Berghen, Charlien, Vandecasteele, Katrien, Vanneste, Ben, Rans, Kato, Liefhooghe, Nick, Wallaert, Steven, Paelinck, Leen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084583/ https://www.ncbi.nlm.nih.gov/pubmed/37016933 http://dx.doi.org/10.1177/15330338231154088

Ejemplares similares

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy
por: Danckaert, Willeke, et al.
Publicado: (2023)

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
por: Rans, Kato, et al.
Publicado: (2022)

Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news
por: Berghen, Charlien, et al.
Publicado: (2020)

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
por: Verghote, Flor, et al.
Publicado: (2021)

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial
por: Draulans, Cédric, et al.
Publicado: (2018)

Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial
por: Berghen, Charlien, et al.
Publicado: (2020)

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
por: Peters, Cedric, et al.
Publicado: (2021)

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy
por: Kemppainen, Reko, et al.
Publicado: (2019)

Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
por: Wan, Juefeng, et al.
Publicado: (2015)

Dosimetric predictors and Lyman normal tissue complication probability model of hematological toxicity in cervical cancer patients with treated with pelvic irradiation
por: Wang, Dandan, et al.
Publicado: (2021)

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
por: Fonteyne, Valérie, et al.
Publicado: (2012)

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial
por: Fonteyne, Valérie, et al.
Publicado: (2017)

Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost
por: Van Hulle, Hans, et al.
Publicado: (2020)

Geometric and dosimetric impact of anatomical changes for MR‐only radiation therapy for the prostate
por: Nejad‐Davarani, Siamak P., et al.
Publicado: (2019)

The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study
por: Poelaert, Filip, et al.
Publicado: (2015)

The Role of Transcatheter Arterial Embolization in Traumatic Pelvic Hemorrhage: Not Only Pelvic Fracture
por: Comai, Alessio, et al.
Publicado: (2016)

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
por: De Wolf, Katrien, et al.
Publicado: (2017)

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol
por: Rammant, Elke, et al.
Publicado: (2017)

Hard times and European youth. The effect of economic insecurity on human values, social attitudes and well‐being
por: Reeskens, Tim, et al.
Publicado: (2016)

IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison
por: Whitaker, Thomas J., et al.
Publicado: (2019)

‘Proper Motions, Actions and Uses’: Physiological Knowledge as the Only Means to Rational Politics in Restoration England
por: RIDGE, STEVE
Publicado: (2011)

Dosimetric evaluation of synthetic CT for magnetic resonance-only based radiotherapy planning of lung cancer
por: Wang, Hesheng, et al.
Publicado: (2017)

Validation of the dosimetric and geometric accuracy of MR-only treatment planning solution for prostate cancer radiotherapy
por: Posiewnik, Michał, et al.
Publicado: (2022)

Dosimetric impact of geometric distortions in an MRI-only proton therapy workflow for lung, liver and pancreas
por: Dumlu, Hatice Selcen, et al.
Publicado: (2020)

Is acetabular dysplasia and pelvic deformity properly interpreted in patients with congenital femoral deficiency? A 3D analysis of pelvic computed tomography
por: Musielak, Bartosz Jan, et al.
Publicado: (2020)

PB2693: ANEMIA IN HEMATOLOGIC MALIGNANCIES: NOT ONLY A SYMPTOM.
por: Hari, Oumayma, et al.
Publicado: (2023)

Intelligence Can Be Used to Make a More Equitable Society but Only When Properly Defined and Applied
por: Holden, LaTasha R., et al.
Publicado: (2021)

Dosimetric evaluation of an atlas‐based synthetic CT generation approach for MR‐only radiotherapy of pelvis anatomy
por: Farjam, Reza, et al.
Publicado: (2018)

Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy
por: Bourbonne, Vincent, et al.
Publicado: (2021)

Validation of an MRI-only planning workflow for definitive pelvic radiotherapy
por: O’Connor, Laura M., et al.
Publicado: (2022)

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
por: Sundahl, Nora, et al.
Publicado: (2017)

Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial
por: De Puysseleyr, Annemieke, et al.
Publicado: (2014)

Evaluation of the Geometric and Dosimetric Accuracy of Synthetic Computed Tomography Images for Magnetic Resonance Imaging-only Stereotactic Radiosurgery
por: Fatemi, Ali, et al.
Publicado: (2019)

Dosimetric evaluation of synthetic CT generated with GANs for MRI‐only proton therapy treatment planning of brain tumors
por: Kazemifar, Samaneh, et al.
Publicado: (2020)

Dosimetric evaluation of synthetic CT image generated using a neural network for MR‐only brain radiotherapy
por: Tang, Bin, et al.
Publicado: (2021)

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
por: De Wolf, Katrien, et al.
Publicado: (2015)

Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
por: Lewis, Shirley, et al.
Publicado: (2017)

Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
por: Devos, Gaëtan, et al.
Publicado: (2019)

Geometric and dosimetric evaluation of the differences between rigid and deformable registration to assess interfraction motion during pelvic radiotherapy
por: White, Ingrid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s4e60k6r6m692ptas0shkdjtmr